The three most widely followed indexes closed a winning week last Friday. The tech-focused Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average advanced 3.5%, 2% and 0.7%, respectively. The holiday-curtailed week was marked by optimism about the Fed shifting gears and cutting interest rates earlier than anticipated. Mega-cap growth stocks like big tech drove the market’s gains. The manufacturing sector and the labor market returned soft numbers, thereby raising investor hope that the Fed would take cognizance and stop delaying rate cuts. Comments made by Fed Chair Jerome Powell from an ECB event in Portugal hinting that the Fed acknowledged the U.S. economy was on a “disinflationary path” also helped raise investor confidence. Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market. As usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action. Here are some of our key achievements: Carvana and New Gold Surge Following Zacks Rank Upgrade Shares of Carvana Co. CVNA have gained 54.4% (versus the S&P 500’s 10.6% increase) since it was upgraded to a Zacks Rank #2 (Buy) on May 1. Another stock, New Gold Inc. NGD, was upgraded to a Zacks Rank #1 (Strong Buy) on May 3 and has returned 17.6% (versus the S&P 500’s 9.9% increase) since then. Zacks Rank, our short-term rating system, has earnings estimate revisions at its core. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. A hypothetical portfolio of Zacks Rank #1 (Strong Buy) stocks returned +20.63% in the year-to-date period through April 1st, 2024, vs. +11.3% for the S&P 500 index and +7.7% for the equal-weight S&P 500 index. This hypothetical portfolio returned +20.63% in 2023 vs. +24.83% for the S&P 500 index and +15% for the equal-weight S&P 500 index. The portfolio of Zacks Rank #1 stocks is an equal-weight portfolio, while the S&P 500 index is a market-cap-weighted index that has been notably distorted by the concentrated performance of mega-cap stocks since October 2022. The Zacks Model Portfolio - consisting of Zacks Rank #1 stocks – has outperformed the S&P index by more than 16 percentage points since 1988 (Through April 1st, 2024, the Zacks # 1 Rank stocks generated an annualized return of +27.6% since 1988 vs. +11.1% for the S&P 500 index).You can see the complete list of today’s Zacks Rank #1 stocks here >>> Check Carvana’s historical EPS and Sales here>>> Check New Gold’s historical EPS and Sales here>>> Zacks Investment Research Image Source: Zacks Investment Research Zacks Recommendation Upgrades Hims & Hers and Napco Higher Shares of Hims & Hers Health, Inc. HIMS and Napco Security Technologies, Inc. NSSC have advanced 78.4% and 18.5% (versus the S&P 500’s 7.4% rise), respectively, since their Zacks Recommendation was upgraded to Outperform on May 7. While the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions. The Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model. To access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>> Zacks Focus List Stocks Sea Limited, Adobe Shoot Up Shares of Sea Limited SE, which belongs to the Zacks Focus List, have gained 34.9% over the past 12 weeks. The stock was added to the Focus List on March 26, 2020. Another Focus-List holding, Adobe Inc. ADBE, which was added to the portfolio on March 13, 2020, has returned 22% over the past 12 weeks. The S&P 500 has advanced 6.9% over this period. The Focus List portfolio returned +10.23% in 2024 Q1 vs. +10.56% for the S&P 500 index and +7.9% for the equal-weight S&P 500 index. The 50-stock Zacks Focus List model portfolio returned +31.44% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio produced -15.2% vs. the S&P 500 index’s -17.96%. Since 2004, the Focus List portfolio has produced an annualized return of +11.91% (through March 31st, 2024). This compares to a +10.25% annualized return for the S&P 500 index in the same time period. Unlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >> Zacks ECAP Stocks Fair Isaac and Costco Make Significant Gains Fair Isaac Corporation FICO, a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 32% over the past 12 weeks. Costco Wholesale Corporation COST has followed Fair Isaac with 21.1% returns. The Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned +9.08% in the year-to-date period (through March 31st, 2024) vs. +10.42%. In 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%. With little to no turnover and annual rebalance periodicity, the ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500. The ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Zacks ECDP Stocks Amgen and Colgate-Palmolive Outshine Peers Amgen Inc. AMGN, which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 16.3% over the past 12 weeks. Another ECDP stock, Colgate-Palmolive Company CL, has climbed 13.1% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance. Check Amgen’s dividend history here>>> Check Colgate-Palmolive’s dividend history here>>> With an extremely low Beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk. The Zacks Earnings Certain Dividend Portfolio (ECDP) returned +4.47% in the year-to-date period (through March 31st, 2024) vs. +10.42% for the S&P 500 index (IVV) and +6.9% for the Dividend Aristocrats ETF (NOBL). The portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL. Click here to access this portfolio on Zacks Advisor Tools. Zacks Top 10 Stocks — Sprouts Farmers Market Delivers Solid Returns Sprouts Farmers Market, Inc. SFM, from the Zacks Top 10 Stocks for 2024, has jumped 71.5% year to date compared with a 16.8% increase for the S&P 500 Index. The Top 10 portfolio returned +19.56% in 2024 Q1 vs. +10.56% for the S&P 500 index and +7.9% for the equal-weight version of the index. The Top 10 portfolio returned +25.15% in 2023 vs. +26.28% for the S&P 500 index. Since 2012, the Top 10 portfolio has produced a cumulative return of +1,060.9% through the end of 2023 vs. +360.1% for the S&P 500 index. Since 2012, the Zacks Top 10 portfolio has produced an annualized return of +25.02% through the end of 2024 Q1 vs. +14.1% for the S&P 500 index and +12.7% for the equal-weight version of the index. The portfolio has produced a cumulative return of +1,442.3% vs. +403.03% for the S&P 500 index and +331.29% for the equal-weight index. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Amgen Inc. (AMGN):Free Stock Analysis Report Colgate-Palmolive Company (CL):Free Stock Analysis Report Sea Limited Sponsored ADR (SE):Free Stock Analysis Report Costco Wholesale Corporation (COST):Free Stock Analysis Report Adobe Inc. (ADBE):Free Stock Analysis Report Fair Isaac Corporation (FICO):Free Stock Analysis Report New Gold Inc. (NGD):Free Stock Analysis Report Sprouts Farmers Market, Inc. (SFM):Free Stock Analysis Report NAPCO Security Technologies, Inc. (NSSC):Free Stock Analysis Report Carvana Co. (CVNA):Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Beat the Market Like Zacks: Carvana, Adobe, Amgen in Focus
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...